Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) has obtained the medical device registration certificate.
Shuo Shi Bioscience (688399.SH) announces that the company has recently received a medical device registration certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration. The product name is the Influenza A H1N1 (2009) and Seasonal Influenza H3 Subtype Virus Nucleic Acid Test Kit (Fluorescent PCR Method). This test kit is used for in vitro qualitative detection of the nucleic acid of Influenza A H1N1 (2009) and seasonal Influenza H3 subtype virus in human throat swab samples.
Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) announced that the company recently received a medical device registration certificate (for in vitro diagnostic reagents) issued by the National Medical Products Administration. The product name is: Influenza A H1N1 (2009) and seasonal H3 subtype influenza virus nucleic acid detection kit (fluorescent PCR method). This kit is used for in vitro qualitative detection of Influenza A H1N1 (2009) and seasonal H3 subtype influenza virus nucleic acid in human throat swab samples.
Related Articles
HENGAN INT'L (01044) spent HKD 9,185,200 to repurchase 340,000 shares on May 6th.
LI AUTO (02015) spent $4.08 million on May 5 to repurchase 452,700 shares.
Lingxiong Technology (02436) spent HK$1.0504 million on May 6 to repurchase 65,100 shares.
HENGAN INT'L (01044) spent HKD 9,185,200 to repurchase 340,000 shares on May 6th.
LI AUTO (02015) spent $4.08 million on May 5 to repurchase 452,700 shares.
Lingxiong Technology (02436) spent HK$1.0504 million on May 6 to repurchase 65,100 shares.
